Product Design Product Strategy

Comprehensive CX Solution for Clinical Trials

2021.04 - 2023.11
Researcher & Designer
20 mins

This is ifa-banner.
01
My Role and my Contribution
My Role and my Contribution

Ensure a consistently stable customer experience across product lines( Construct, LLM-Based AI Experience and Compute), diverse professional backgrounds, and trial periods.

02
First encounter with DCT
First encounter with DCT

COVID-19 was the catalyst for hybrid clilinal trial. Sponsors and investigators are overcoming the administrative and bureaucratic hurdles to provide more patient centric clinical trials. Incorporating novel technology for enrollment and trial conduct will become the new norm. Aim to alleviate the burden on patients as well.

Remote technologies provides convenience to patients and thereby enhancing their participation experience. The use of digital tools can effectively reduce the growing costs of trials and address the escalating demands for data. So we think it's for us to explore this novel study model.

03
My study Methods: As-Is & To-Be
My study Methods: As-Is & To-Be

The process primarily employed the "as-is" and "to-be" methods. It involved documenting and analyzing the current state or processes within a system, providing a baseline understanding of the existing situation. On the other hand, it outlined the desired future state or improvements, offering a vision of the intended changes and guiding the transition from the current state to the envisioned state.

04
Utilize a Stakeholder Map to simplify complex hybrid clinical operation system
Utilize a Stakeholder Map to simplify complex hybrid clinical operation system

What did I gain from doing this? These analyses helped me at least at 3 points:
1. Get a full picture and increased awareness of this co-work service system
2. Get a shared understanding of the landscape among our team
3. Facilitate smoother onboarding for new team members

05
How does the application of a Decentralized Clinical Trial (DCT) differ from that of a traditional clinical trial?
How does the application of a Decentralized Clinical Trial (DCT) differ from that of a traditional clinical trial?

In the context of a DCT, the most impacted stakeholders are the sponsor and patients. But what are the main differences between applying a DCT and a traditional clinical trial? What services should I be capable of providing for these changes? A thorough understanding will assist me in overcoming the upcoming challenges.

06
Utilize Empathy Map to build a Holistic Customer Profile
Utilize Empathy Map to build a Holistic Customer Profile

There are many stakeholders I have to collaborate with. And I categorize the stakeholders into 4 groups. 2 of them are: critical stakeholders (Key Players), whom I will manage carefully, and major stakeholders, whose needs I will prioritize.

Key Words Summary of A Hybrid Clinical Study System Should Be
07
Holistic Customer Journey
Holistic Customer Journey

Diagnose the holistic journey through the use of journey map tools, identify the weekness of the holistic journey, then prioritize pain points and seek the potential opportunities. Finally, explore potential synthesized solutions for system design with my team members.

08
To-be Experience
To-be Experience

Based on the comprehensive situation analysis and in alignment with the company's vision, we aspire to provide a one-stop software service. This service aims to enable intelligent coverage throughout the entire experimental process, ranging from swiftly establishing a database for experiment plans to generating data collection interfaces with a single click. It encompasses direct device data collection and extends support to various scenarios such as laboratory and remote data collection. Furthermore, it includes statistical analysis based on industry regulations and the automatic generation of safety and efficacy outcomes.

09
How We Put the Professional Experience and Patient Experience at the Forefront
How We Put the Professional Experience and Patient Experience at the Forefront

Brand Is Experience in the Digital Age. And UX Is a Brand Differentiator. Brand is the holistic sum of customers's experiences, composed of visual, tonal and behavioral brand components, many of which are shaped by interaction design. UX can be part of — or all of — the reason a customer chooses to engage with a company or its products.

10
System Design Highlights
System Design Highlights
Professional-Centricity

In the existing process, a challenging aspect was the writing of logic. CRO Technical Director aimed to ensure the data compliance with trial logic. However, for complex logic such as time window comparisons (checking if the time is within a 5-minute absolute value of the administration time, triggering an EDC query otherwise), Custom Function Scripts needed to be written. This increased the entry barrier for industry professionals and slowed down the trial implementation process.

Take a glance at the design I created below. It is interactive, catching users' attention all the way all the time by providing timely hint and support(Perceivable Affordance) for our end users to compose a valid expression. This solution is infused with fascination throughout the journey. Make boring daily work fun! Fostering a sense of accomplishment in their work.

👉🏻 If you want to dive into the detail about how I polish this tool, pls check this link

How to compose an Edit Check in Logic Engine - Provide Affordance for Fixing Mistakes
Patient-Centricity
11
Value of Product and Service
Value of Product and Service

Always based on a good experience and interface design, a positive customer journey not only enhances customer satisfaction but also leads to better business outcomes (such as revenue, customer retention, and repeat purchases). Managing any type of customer experience involves predicting the current needs of individual customers and proactively meeting these needs, ultimately creating a seamless, enjoyable, and fulfilling brand experience.

12
How I Manage Customer Journey
How I Manage Customer Journey

The Engagement Matrix helps me effectively manage my stakeholders by strategically organizing and prioritizing their input based on varying levels of importance. It enables me to systematically address and optimize priorities according to the significance of each stakeholder.

13
How I Manage Product Performance
How I Manage Product Performance

It is impossible to solve pain points in a one-time manner. Solutions are often prioritized based on the classification and impact of the pain points, requiring careful consideration and strategic utilization of user experience resources. Potential solutions are proposed for optimization. The identification and management of pain points typically fall into three categories

1. Interaction Level

User validation, user interviews, and tracking data are all essential components in the process.

2. Journey Level

Customer demands at wechat community, regular organizational interviews, and metrics such as revenue, churn, and repeat purchases are all considered.

3. Relationship Level

Longitude validation, experimentation guidance with CRO and site, empathy with our participants, contextual inquiry studies, NPS (Net Promoter Score), brand loyalty, and customer satisfaction surveys are conducted. This aids in accelerating their achievement of industry digitization and product design experiences.

14
Here are what I consider to be the trends of clinical trials
Here are what I consider to be the trends of clinical trials

1. Digital innovation Empower Clinical:Digital innovation is empowering clinical processes, permeating every stage from the initiation to the execution and follow-up of clinical research. It is gradually extending its influence into areas such as clinical trial management, remote monitoring, drug safety monitoring, and real-world studies.
2. Patient Experience Data to Evaluate Medical Interventions: A variety of different PED research methods, including literature reviews, interviews and focus groups, administration of clinical outcome assessments (COAs), preference surveys, and the use of digital health tools, can be used to generate PED
3. New Drug Benefit-Risk Assessment. Patients will increasingly focus on the benefit-risk assessment of new drugs, evaluating the balance between the benefits and risks that come with treating a particular disease. This assessment is aimed at ensuring that patients receive the maximum therapeutic benefits while minimizing potential adverse events and risks.
4. Pharmaceutical Economics. Enterprises will increasingly leverage pharmacoeconomics, starting from the field of pharmacoeconomics, to most effectively utilize drugs and medical resources to enhance patient health. With a focus on patients, this approach involves evidence-based digital innovation.
5. Sustainable. Sustainably reducing carbon emissions can help alleviate some of the environmental hazards that impact public health.
6. More AI Solution. Exploration of future scenarios involves the design of AI products.

Previous:
Construct Product Design 0 to 1 Case Retro Sharing
Next:
LLM-Based Experience Design